Artist 1

Trial description
A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compared with FOLFOX Alone as Second-line Therapy in Patients with Metastatic Pancreatic Cancer that has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Contact name
Dr Pippa Corrie
Trial start date
Friday, July 21, 2017
Trial end date
Monday, December 30, 2019
Trial tumour type
Pancreatic
Show on Radiotherapy
No